Zogenix, Inc.
22
1
2
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
9.1%
2 terminated/withdrawn out of 22 trials
88.9%
+2.3% vs industry average
32%
7 trials in Phase 3/4
31%
5 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
Role: lead
Fenfluramine for Adult Dravet Patients
Role: collaborator
A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.
Role: lead
A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome
Role: lead
Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes
Role: collaborator
European Non-interventional Study on Refractory Epilepsy With Developmental Delay
Role: lead
ZX008 Expanded Access Protocol
Role: lead
Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy
Role: collaborator
A Study on the Effects of Repeat Doses of Intraject® Sumatriptan on Local Site Signs
Role: lead
Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain
Role: lead
A Safety, Tolerability and Pharmacokinetic Dose Escalation Study of HC-ER in Patients With Osteoarthritis Pain
Role: lead
A Multicenter Active Comparator Study of HC-ER in Adults Following Bunionectomy Surgery
Role: lead
A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System
Role: lead
Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Controlled-Release (HC-CR) in Subjects With Hepatic Impairment
Role: lead
A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine Attack
Role: lead
To Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release Capsules
Role: lead
A Study to Determine the Influence of Co-ingestion of Alcohol on Hydrocodone Bitartrate Extended Release (HC-ER)
Role: lead
A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia
Role: lead
A Study on the Intraject Instructions for Use
Role: lead
Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) in Subjects With Renal Impairment
Role: lead